Pfizer unveils additional $2.5B in planned cost savings through 2029

Pfizer will reduce its costs by $2.5 billion in another round of cutbacks which will kick in next year and run through 2029. | Pfizer will reduce its costs by $2.5 billion in another round of cutbacks which will begin next year and run through 2029. The additional cost savings swell Pfizer's program to $9.7 billion in reductions.